What is CalAmp's change in AP?

CalAmp (CAMP) reported change in AP of $592K in Q1 2026.

How has CalAmp's change in AP changed year-over-year?

CalAmp's change in AP increased by 238.3% year-over-year, from $175K to $592K.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

CalAmp CAMP Change in AP

Change in AP at other companies

Ionis PharmaceuticalsIONS

-$3.1M+88.1%

Rapport Therapeutics, Inc.RAPP

$2.31M+1,146%

MeiraGTx Holdings plcMGTX

$7.91M+358%

Polaryx Therapeutics, Inc. PLYX

$380K+2,335%

Taysha Gene Therapies, Inc.TSHA

$1.29M+39.7%

CytomX TherapeuticsCTMX

$67K+108%

Other financials

Income statement

See full

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

See full

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

See full

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

See full

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

See full

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

See full

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CalAmp's change in AP?: CalAmp (CAMP) reported change in AP of $592K in Q1 2026.
How has CalAmp's change in AP changed year-over-year?: CalAmp's change in AP increased by 238.3% year-over-year, from $175K to $592K.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.